Published in Neuromuscul Disord on September 28, 2005
Pathogenic point mutations in a transmembrane domain of the epsilon subunit increase the Ca2+ permeability of the human endplate ACh receptor. J Physiol (2007) 0.88
Mutations Causing Slow-Channel Myasthenia Reveal That a Valine Ring in the Channel Pore of Muscle AChR is Optimized for Stabilizing Channel Gating. Hum Mutat (2016) 0.77
Recent advances in Cys-loop receptor structure and function. Nature (2006) 4.20
Mutations in myotilin cause myofibrillar myopathy. Neurology (2004) 2.41
Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology (2007) 2.14
Electromyographic findings in 37 patients with adult-onset acid maltase deficiency. Muscle Nerve (2015) 2.07
Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol (2009) 2.03
Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol (2005) 1.80
Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain (2004) 1.80
Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol (2003) 1.77
Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. Am J Hum Genet (2002) 1.61
Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology (2004) 1.54
Myasthenic syndrome caused by mutation of the SCN4A sodium channel. Proc Natl Acad Sci U S A (2003) 1.50
Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation. Neuromuscul Disord (2010) 1.50
Highly fatal fast-channel syndrome caused by AChR ε subunit mutation at the agonist binding site. Neurology (2012) 1.49
Phenotypic heterogeneity in a large Thai slow-channel congenital myasthenic syndrome kinship. Neuromuscul Disord (2011) 1.41
Mutation causing severe myasthenia reveals functional asymmetry of AChR signature cystine loops in agonist binding and gating. J Clin Invest (2003) 1.36
126th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands. Neuromuscul Disord (2005) 1.35
Sporadic late onset nemaline myopathy. Neurology (2005) 1.32
Naturally occurring mutations at the acetylcholine receptor binding site independently alter ACh binding and channel gating. J Gen Physiol (2002) 1.23
The human adult subtype ACh receptor channel has high Ca2+ permeability and predisposes to endplate Ca2+ overloading. J Physiol (2006) 1.16
Reconstitution of paired T cell receptor alpha- and beta-chains from microdissected single cells of human inflammatory tissues. Proc Natl Acad Sci U S A (2006) 1.14
Structural abnormalities at neuromuscular synapses lacking multiple syntrophin isoforms. J Neurosci (2004) 1.12
Slow-channel mutation in acetylcholine receptor alphaM4 domain and its efficient knockdown. Ann Neurol (2006) 1.12
Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1. Ann Neurol (2013) 1.11
C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse. J Biol Chem (2003) 1.08
Commonality of TRIM32 mutation in causing sarcotubular myopathy and LGMD2H. Ann Neurol (2005) 1.05
Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia. Muscle Nerve (2011) 1.05
Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients. Ann Neurol (2008) 1.05
Congenital myasthenia-related AChR delta subunit mutation interferes with intersubunit communication essential for channel gating. J Clin Invest (2008) 1.04
A new muscle glycogen storage disease associated with glycogenin-1 deficiency. Ann Neurol (2014) 1.03
Choline acetyltransferase structure reveals distribution of mutations that cause motor disorders. EMBO J (2004) 1.02
hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Hum Mol Genet (2008) 1.00
E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome. Hum Mol Genet (2003) 0.99
Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations. Muscle Nerve (2011) 0.98
Treatment of myotonia with antiarrhythmic drugs. Acta Neurol Scand (1992) 0.97
Tannic acid facilitates expression of the polypyrimidine tract binding protein and alleviates deleterious inclusion of CHRNA1 exon P3A due to an hnRNP H-disrupting mutation in congenital myasthenic syndrome. Hum Mol Genet (2009) 0.96
Myasthenic syndrome AChRα C-loop mutant disrupts initiation of channel gating. J Clin Invest (2012) 0.95
Subunit-specific contribution to agonist binding and channel gating revealed by inherited mutation in muscle acetylcholine receptor M3-M4 linker. Brain (2004) 0.95
Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine. Neuromuscul Disord (2004) 0.94
Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology (2003) 0.93
LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner. Hum Mol Genet (2013) 0.91
Congenital myasthenic syndromes: gene mutations. Neuromuscul Disord (2004) 0.90
Pathogenic point mutations in a transmembrane domain of the epsilon subunit increase the Ca2+ permeability of the human endplate ACh receptor. J Physiol (2007) 0.88
Teaching neuroimages: hydroxychloroquine-induced vacuolar myopathy. Neurology (2013) 0.87
Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology (2011) 0.86
Functional consequences and structural interpretation of mutations of human choline acetyltransferase. Hum Mutat (2011) 0.85
Congenital myasthenic syndromes: genetic defects of the neuromuscular junction. Curr Neurol Neurosci Rep (2002) 0.85
Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers. Am J Pathol (2011) 0.84
Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia. Neuromuscul Disord (2011) 0.84
Myofibrillar myopathies. Handb Clin Neurol (2011) 0.84
Follow-up study of myasthenic children after thymectomy. J Neurol (1977) 0.83
Motor and sensory conduction velocity in spinal muscular atrophy. Follow-up study. Electromyogr Clin Neurophysiol (1978) 0.83
A frameshifting mutation in CHRNE unmasks skipping of the preceding exon. Hum Mol Genet (2003) 0.83
PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome. Neurology (2014) 0.83
GFPT1-myasthenia: clinical, structural, and electrophysiologic heterogeneity. Neurology (2013) 0.83
HnRNP L and hnRNP LL antagonistically modulate PTB-mediated splicing suppression of CHRNA1 pre-mRNA. Sci Rep (2013) 0.82
Neuromuscular junction acetylcholinesterase deficiency responsive to albuterol. Pediatr Neurol (2012) 0.82
Effects of ginsenosides, active components of ginseng, on nicotinic acetylcholine receptors expressed in Xenopus oocytes. Eur J Pharmacol (2002) 0.82
"Cap disease": new congenital myopathy. Neurology (1981) 0.81
Splicing abnormalities in congenital myasthenic syndromes. Acta Myol (2005) 0.81
Muscle pathology in 31 patients with calpain 3 gene mutations.. Neurol Neurochir Pol (2013) 0.80
Autosomal recessive axonal form of Charcot-Marie-Tooth Disease caused by compound heterozygous 3'-splice site and Ser130Cys mutation in the GDAP1 gene. Neuropediatrics (2005) 0.80
How accurate is spirometry at predicting restrictive pulmonary impairment in children with myasthenia gravis. J Physiol Pharmacol (2006) 0.79
Familial cardioneuromyopathy with hyaline masses and nemaline rods: a novel phenotype. Ann Neurol (2002) 0.79
Antititin antibody in early- and late-onset myasthenia gravis. Acta Neurol Scand (2014) 0.78
Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis. Chem Biol Interact (2012) 0.78
Scapuloperoneal muscular dystrophy phenotype due to TRIM32-sarcotubular myopathy in South Dakota Hutterite. Neuromuscul Disord (2012) 0.78
The subclinical facial nerve involvement in generalized neuropathies. Electromyogr Clin Neurophysiol (1987) 0.78
Congenital myasthenic syndromes:gene mutations. Neuromuscul Disord (2003) 0.78
A novel MPZ gene mutation in congenital neuropathy with hypomyelination. Neurology (2004) 0.77
A new familial congenital myopathy in children with desmin and dystrophin reacting plaques. J Neurol Sci (1995) 0.76
[Conduction velocity in peripheral nerves in healthy and sick children]. Neurol Neurochir Pol (1976) 0.76
Inclusion-body myositis presenting with facial diplegia. Muscle Nerve (2013) 0.76
An X:autosome translocation stabilizes truncated dystrophin: implications for lack of truncated dystrophins in Duchenne muscular dystrophy. Neuropediatrics (1995) 0.75
Recent structural and mechanistic insights into endplate acetylcholine receptors. Ann N Y Acad Sci (2008) 0.75
On chaos in classification of childhood spinal muscular atrophy. Neuromuscul Disord (1992) 0.75
Muscle restricted vasculitis causing dropped head syndrome: a case report and review of the literature. J Clin Neuromuscul Dis (2012) 0.75
[Electromyographic aspects of non-progressive myopathies]. Neurol Neurochir Pol (1972) 0.75
[Diagnostic problems in Dubovitz syndrome]. Pediatr Pol (1973) 0.75
[Electromyographic findings in children with dermatomyositis]. Neurol Neurochir Pol (1984) 0.75
Is central core disease with structural core a fetal defect? J Neurol (1984) 0.75
[Idiopathic juvenile osteoporosis with the symptoms suggesting nervous system damage]. Neurol Neurochir Pol (1990) 0.75
Lipid storage myopathy in Kearns-Sayre syndrome. Neurology (1985) 0.75
[Sensorimotor hereditary neuropathy. IV. Clinical, electrophysiologic and histologic correlations. Summary of studies]. Neurol Neurochir Pol (1987) 0.75
[Hereditary motor and sensory neuropathy. I. Principles of classification and clinical picture]. Neurol Neurochir Pol (1986) 0.75
[Hypochondroplasia]. Chir Narzadow Ruchu Ortop Pol (1976) 0.75
[Isaacs-Mertens syndrome: continuous activity of motor units]. Neurol Neurochir Pol (1987) 0.75
[Evaluation of the muscular system in children with congenital multi-joint instability and congenital hip dislocation]. Chir Narzadow Ruchu Ortop Pol (1985) 0.75
The diagnostic yield of automatic EMG analysis in neuromuscular diseases. Acta Physiol Pol (1988) 0.75
[Motor-sensory hereditary neuropathy. III. Histological changes]. Neurol Neurochir Pol (1987) 0.75
Correlative morphological and biochemical studies in a case of subacute progressive panencephalomyelitis caused by paramyxovirus. Neuropatol Pol (1982) 0.75
[Non-progressing myopathies as a cause of flaccidity in children]. Pediatr Pol (1972) 0.75
Some electrophysiological and immunological problems in Werdnig--Hoffmann disease. Acta Univ Carol Med Monogr (1976) 0.75
Motor nerve function in some neurological syndromes in children. Electromyogr Clin Neurophysiol (1976) 0.75
[Electrophysiological studies of peripheral nerves in children with various grades of chronic renal failure]. Pol Tyg Lek (1982) 0.75
[Case of late infantile form of gangliosidosis G-M1]. Neurol Neurochir Pol (1975) 0.75
[Hereditary motor-sensory neuropathy. II. Electrophysiological studies]. Neurol Neurochir Pol (1986) 0.75
Preliminary immunological studies in spinal muscular atrophy. Eur J Pediatr (1978) 0.75
Electromyographic findings in the so-called non-progressive myopathies. J Neurol (1976) 0.75
[Case of infantile myoclonic encephalopathy]. Pediatr Pol (1977) 0.75